BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 28941018)

  • 21. MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancer.
    Chapman BV; Wald AI; Akhtar P; Munko AC; Xu J; Gibson SP; Grandis JR; Ferris RL; Khan SA
    BMC Cancer; 2015 Nov; 15():861. PubMed ID: 26545583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptome sequencing uncovers novel long noncoding and small nucleolar RNAs dysregulated in head and neck squamous cell carcinoma.
    Zou AE; Ku J; Honda TK; Yu V; Kuo SZ; Zheng H; Xuan Y; Saad MA; Hinton A; Brumund KT; Lin JH; Wang-Rodriguez J; Ongkeko WM
    RNA; 2015 Jun; 21(6):1122-34. PubMed ID: 25904139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel insights into laryngeal squamous cell carcinoma from association study of aberrantly expressed miRNAs, lncRNAs and clinical features in Bulgarian patients.
    Garo Kyurkchiyan S; Miroslavov Popov T; Stancheva G; Rangachev J; Ivanov Mitev V; Petrova Popova D; Petrova Kaneva R
    J BUON; 2020; 25(1):357-366. PubMed ID: 32277655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus.
    Wald AI; Hoskins EE; Wells SI; Ferris RL; Khan SA
    Head Neck; 2011 Apr; 33(4):504-12. PubMed ID: 20652977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of aberrantly expressed microRNAs in the pathogenesis of head and neck squamous cell carcinoma.
    Koshizuka K; Hanazawa T; Arai T; Okato A; Kikkawa N; Seki N
    Cancer Metastasis Rev; 2017 Sep; 36(3):525-545. PubMed ID: 28836104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma.
    Sano D; Oridate N
    Int J Clin Oncol; 2016 Oct; 21(5):819-826. PubMed ID: 27339270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma.
    Cao W; Liu JN; Liu Z; Wang X; Han ZG; Ji T; Chen WT; Zou X
    Oral Oncol; 2017 Feb; 65():94-101. PubMed ID: 28109476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas.
    Sailer V; Charpentier A; Dietrich J; Vogt TJ; Franzen A; Bootz F; Dietrich D; Schroeck A
    PLoS One; 2018; 13(2):e0192742. PubMed ID: 29425237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miRNA-expression in tonsillar squamous cell carcinomas in relation to HPV infection and expression of the antileukoproteinase SLPI.
    Quabius ES; Merz I; Görögh T; Hedderich J; Haag J; Röcken C; Ambrosch P; Hoffmann M
    Papillomavirus Res; 2017 Dec; 4():26-34. PubMed ID: 29179866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MALAT1-miR-124-RBG2 axis is involved in growth and invasion of HR-HPV-positive cervical cancer cells.
    Liu S; Song L; Zeng S; Zhang L
    Tumour Biol; 2016 Jan; 37(1):633-40. PubMed ID: 26242259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging cell cycle related non-coding RNA biomarkers from saliva and blood for oral squamous cell carcinoma.
    Kalmatte A; Rekha PD; Ratnacaram CK
    Mol Biol Rep; 2023 Nov; 50(11):9479-9496. PubMed ID: 37717257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene.
    Liu CJ; Shen WG; Peng SY; Cheng HW; Kao SY; Lin SC; Chang KW
    Int J Cancer; 2014 Feb; 134(4):811-21. PubMed ID: 23824713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The contributory role of long non-coding RNAs (lncRNAs) in head and neck cancers: Possible biomarkers and therapeutic targets?
    Akbari Dilmaghani N; Khoshsirat S; Shanaki-Bavarsad M; Pourbagheri-Sigaroodi A; Bashash D
    Eur J Pharmacol; 2021 Jun; 900():174053. PubMed ID: 33766619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A miR-centric view of head and neck cancers.
    Babu JM; Prathibha R; Jijith VS; Hariharan R; Pillai MR
    Biochim Biophys Acta; 2011 Aug; 1816(1):67-72. PubMed ID: 21549178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Drivers of Head and Neck Squamous Cell Carcinoma: Aberrant Splicing Events, Mutational Burden, HPV Infection and Future Targets.
    Dlamini Z; Alaouna M; Mbatha S; Bhayat A; Mabongo M; Chatziioannou A; Hull R
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33804181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression profiles in HPV-infected head and neck cancer.
    Schlecht NF; Burk RD; Adrien L; Dunne A; Kawachi N; Sarta C; Chen Q; Brandwein-Gensler M; Prystowsky MB; Childs G; Smith RV; Belbin TJ
    J Pathol; 2007 Nov; 213(3):283-93. PubMed ID: 17893858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The Role of microRNA in head and neck cancer focusing on sinonasal carcinoma].
    Kovaříková H; Chmelařová M; Palička V
    Cas Lek Cesk; 2016; 155(2):45-50. PubMed ID: 27088793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of HPV-16 infection on hypopharyngeal squamous cell carcinoma and FaDu cells.
    Lu W; Feng L; Li P; Wang Y; Du Y; Chen X; Wu S; Zhao G; Lou W
    Oncol Rep; 2016 Jan; 35(1):99-106. PubMed ID: 26497405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miRNAs in head and neck cancer revisited.
    Nagadia R; Pandit P; Coman WB; Cooper-White J; Punyadeera C
    Cell Oncol (Dordr); 2013 Feb; 36(1):1-7. PubMed ID: 23338821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
    He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
    Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.